Chargement en cours...
Adjuvant Endocrine Therapy in Premenopausal Patients
Endocrine adjuvant therapy is the best-described molecular targeted treatment and should therefore be used for all patients with endocrine-responsive breast cancer. Ta-moxifen for 5 years is standard of care and has proven efficacy in premenopausal patients. The combination of tamoxifen with ovarian...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931102/ https://ncbi.nlm.nih.gov/pubmed/20824025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156985 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|